Dry January doesn't have to mean sober January — at least for the 21 percent of participants turning to cannabis or CBD to make it through the month.
According to a survey by Civic Science, 67 percent of Dry January participants, or those choosing to abstain from alcohol consumption for the month of January, reported they are replacing alcohol with something — whether that be mocktails and alcohol-free beers or sodas and seltzers.
The largest share, 21 percent, said they would enjoy cannabis or non-psychoactive CBD in place of alcohol. The preference for substitutes wasn't uniform across all respondents. Cannabis was the most popular substitute among the youngest respondents with 34 percent of 21- to 24-year-olds preferring it. Among the 55 and older crowd, by contrast, just 9 percent reported they'd enjoy cannabis or CBD instead of alcohol, and 54 percent reported they'd stay the course without any support.
Dry January's Growing Popularity
Interest in Dry January has climbed over the recent years. At the close of 2022, about 41 percent of respondents in a separate survey by Civic Science reported they were "somewhat to very likely" to participate in Dry January come 2023. That's in-line with pre-pandemic data for the start of 2020, but slightly behind 2022 responses, which rebounded after a lag in interest during the 2021 pandemic year.
As with the preference for cannabis, interest in Dry January tends to vary by age — and younger generations are leading the charge. For the year of 2023, more than half of the youngest respondents, aged 21 to 24 years old, said they were "somewhat to very likely" to participate versus just 41 percent of those 55 and older.
Studies suggest social media is contributing to a growing reluctance to drink with younger generations fearful of consequences if their drunk escapades are documented on the internet. According to 2019 research from Google, 49 percent of Generation Z reports their image online is "always at the back of their mind when they go out socializing and drinking." Some 76 percent reported it is important to have control of "all aspects of their life at all times," according to the research.
Carlo and Baker cover the latest developments after a devastating tornado outbreak over the weekend, plus an eye on Omicron and inflation, and not even Spielberg can save the box office.
Reusable rocket developer Stoke Space Technologies raised $65 million in a Series A round led by Breakthrough Energy Ventures, a firm founded by Bill Gates. Stoke says its reusable rockets provide the satellite industry with low-cost, on-demand access to and from orbit. As companies like SpacX and Blue Origin are also making commitments to rocket reusability, Stoke says it is taking a different approach with a system designed to be 100% reusable, comprised of rockets designed to fly daily, like an airplane. Stoke co-founder and CEO Andy Lapsa joins Cheddar News' Closing Bell to discuss.
Humans are set to return to a place we have not been in nearly 50 years: the moon. NASA's Artemis program is expected to have astronauts back on the lunar surface by 2025. NASA says it will use what it learns on the moon to take the next giant leap - sending the first astronauts to Mars. The Artemis program also includes contributions from private companies like SpaceX, as well as academic research institutions like Georgia Tech. Georgia Tech professor of practice and former NASA astronaut Sandra Magnus joins Future of Space: Humankind's Leap Forward to discuss.
The CDC warns that COVID-19 is rapidly spreading with Omicron variant cases doubling every two days in the United States. How do current vaccines hold up against the new strain, and what does it mean for your upcoming holiday travel? Cheddar News breaks things down with infectious diseases specialist Dr. William Schaffner of Vanderbilt University School of Medicine.
President Joe Biden is expected to meet with his COVID-19 response team as the omicron variant continues to surge across the country. Experts say Delta is driving this surge but Dr. Anthony Fauci says Omicron will take over. Emergency physician Dr. Daniel Fagbuyi joins Cheddar News to discuss.
Omicron is on course to become the dominant COVID strain in the U.S., even as Delta is causing another spike in cases. According to Johns Hopkins University data, cases across the country are up 40% from last month, with New York City as a major hotspot. Outbreaks are now causing Broadway performances to be canceled, colleges and universities to shift to online classes, sports leagues to postpone games, and more. Dr. Jen Caudle, family physician and associate professor at Rowan University, joined Cheddar to discuss the surge in cases and how we can best protect ourselves against the new variant.
